
Cancer Cell, Год журнала: 2021, Номер 40(2), С. 185 - 200.e6
Опубликована: Дек. 23, 2021
Язык: Английский
Cancer Cell, Год журнала: 2021, Номер 40(2), С. 185 - 200.e6
Опубликована: Дек. 23, 2021
Язык: Английский
eLife, Год журнала: 2021, Номер 10
Опубликована: Май 4, 2021
Culture-independent analyses of microbial communities have progressed dramatically in the last decade, particularly due to advances methods for biological profiling via shotgun metagenomics. Opportunities improvement continue accelerate, with greater access multi-omics, reference genomes, and strain-level diversity. To leverage these, we present bioBakery 3, a set integrated, improved taxonomic, strain-level, functional, phylogenetic metagenomes newly developed build on largest sequences now available. Compared current alternatives, MetaPhlAn 3 increases accuracy taxonomic profiling, HUMAnN improves that functional potential activity. These detected novel disease-microbiome links applications CRC (1262 metagenomes) IBD (1635 817 metatranscriptomes). Strain-level an additional 4077 StrainPhlAn PanPhlAn unraveled structure common gut microbe Ruminococcus bromii , previously described by only 15 isolate genomes. With open-source implementations cloud-deployable reproducible workflows, platform can help researchers deepen resolution, scale, multi-omic community studies.
Язык: Английский
Процитировано
1374Nature reviews. Immunology, Год журнала: 2021, Номер 21(7), С. 426 - 440
Опубликована: Янв. 28, 2021
Язык: Английский
Процитировано
1010Nature Reviews Gastroenterology & Hepatology, Год журнала: 2019, Номер 16(11), С. 690 - 704
Опубликована: Сен. 25, 2019
Язык: Английский
Процитировано
978Science, Год журнала: 2021, Номер 371(6536)
Опубликована: Март 25, 2021
Microbial roles in cancer formation, diagnosis, prognosis, and treatment have been disputed for centuries. Recent studies provocatively claimed that bacteria, viruses, and/or fungi are pervasive among cancers, key actors immunotherapy, engineerable to treat metastases. Despite these findings, the number of microbes known directly cause carcinogenesis remains small. Critically evaluating building frameworks such evidence light modern biology is an important task. In this Review, we delineate between causal complicit trace common themes their influence through host's immune system, herein defined as immuno-oncology-microbiome axis. We further review intratumoral approaches manipulate gut or tumor microbiome while projecting next phase experimental discovery.
Язык: Английский
Процитировано
872Gastroenterology, Год журнала: 2019, Номер 158(2), С. 322 - 340
Опубликована: Окт. 3, 2019
Язык: Английский
Процитировано
591Nature Reviews Clinical Oncology, Год журнала: 2020, Номер 18(4), С. 230 - 243
Опубликована: Ноя. 20, 2020
Язык: Английский
Процитировано
448The Lancet. Gastroenterology & hepatology, Год журнала: 2022, Номер 7(3), С. 262 - 274
Опубликована: Янв. 26, 2022
Язык: Английский
Процитировано
431Cell Host & Microbe, Год журнала: 2022, Номер 30(3), С. 289 - 300
Опубликована: Март 1, 2022
Язык: Английский
Процитировано
424Frontiers in Immunology, Год журнала: 2020, Номер 11
Опубликована: Ноя. 30, 2020
The intestinal microbiota, composed of a large population microorganisms, is often considered "forgotten organ" in human health and diseases. Increasing evidence indicates that dysbiosis the microbiota closely related to colorectal cancer (CRC). roles for microorganisms initiated facilitated CRC process are becoming increasingly clear. Hypothesis models have been proposed illustrate complex relationship between CRC. Recent studies identified Streptococcus bovis, enterotoxigenic Bacteroides fragilis, Fusobacterium nucleatum, Enterococcus faecalis, Escherichia coli, Peptostreptococcus anaerobius as candidate pathogens. In this review, we summarized mechanisms involved microbiota-related carcinogenesis, including inflammation, pathogenic bacteria, their virulence factors, genotoxins, oxidative stress, bacterial metabolites, biofilm. We also described clinical values novel strategies preventing treating
Язык: Английский
Процитировано
400Signal Transduction and Targeted Therapy, Год журнала: 2023, Номер 8(1)
Опубликована: Март 20, 2023
Metabolic abnormalities lead to the dysfunction of metabolic pathways and metabolite accumulation or deficiency which is well-recognized hallmarks diseases. Metabolite signatures that have close proximity subject's phenotypic informative dimension, are useful for predicting diagnosis prognosis diseases as well monitoring treatments. The lack early biomarkers could poor serious outcomes. Therefore, noninvasive methods with high specificity selectivity desperately needed. Small molecule metabolites-based metabolomics has become a specialized tool biomarker pathway analysis, revealing possible mechanisms human various deciphering therapeutic potentials. It help identify functional related variation delineate biochemical changes indicators pathological damage prior disease development. Recently, scientists established large number profiles reveal underlying networks target exploration in biomedicine. This review summarized analysis on potential value small-molecule candidate metabolites clinical events, may better diagnosis, prognosis, drug screening treatment. We also discuss challenges need be addressed fuel next wave breakthroughs.
Язык: Английский
Процитировано
361